beta

AMPE

Ampio Pharmaceuticals Inc.

Ampe

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

08-14-2018 05-12-2017
Actual EPS 0.05 -0.05
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Ampio Pharmaceuticals Inc is a biopharmaceutical company. The company is engaged in the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options.

Market Cap: 199 Million

Primary Exchange: NYSE American

Website: http://www.ampiopharma.com

Shares Outstanding: 75.9 Million

Float: 73.5 Million

Dividend: 0.0 (0.0%)

Beta: 0.070971

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 11 Million

Ethical Flags

Animal testing

Longest drawdown: 1283 trading days

From: 2013-10-24 To: 2018-12-07

Lowest Point:

Ampio Updates Regulatory and Publication status for Ampion(TM)

via: PR Newswire at 2018-11-26 08:30:00:000

ENGLEWOOD, Colo. , Nov. 26, 2018 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today updates the regulatory and peer-review publication status of Ampion. Regulatory update: Statisticians representing Ampio and the FDA met recently to discuss the clinical pathwa… read more...

Ampio Updates Regulatory and Publication status for Ampion(TM)

via: PR Newswire at 2018-11-26 08:30:00:000

ENGLEWOOD, Colo. , Nov. 26, 2018 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today updates the regulatory and peer-review publication status of Ampion. Regulatory update: Statisticians representing Ampio and the FDA met recently to discuss the clinical pathwa… read more...

Ampio Updates Regulatory and Publication status for Ampion(TM)

via: PR Newswire at 2018-11-26 08:30:00:000

ENGLEWOOD, Colo. , Nov. 26, 2018 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today updates the regulatory and peer-review publication status of Ampion. Regulatory update: Statisticians representing Ampio and the FDA met recently to discuss the clinical pathwa… read more...

Ampio Updates Regulatory and Clinical Status for Ampion(TM)

via: PR Newswire at 2018-11-07 08:30:00:000

ENGLEWOOD, Colo. , Nov. 7, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today is providing an update of the regulatory and clinical path activities required to file a Biologics License Application (BLA) for Ampion for the treatment of severe osteoarthriti… read more...

Ampio Updates Regulatory and Clinical Status for Ampion(TM)

via: PR Newswire at 2018-11-07 08:30:00:000

ENGLEWOOD, Colo. , Nov. 7, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today is providing an update of the regulatory and clinical path activities required to file a Biologics License Application (BLA) for Ampion for the treatment of severe osteoarthriti… read more...

Ampio Updates Regulatory and Clinical Status for Ampion(TM)

via: PR Newswire at 2018-11-07 08:30:00:000

ENGLEWOOD, Colo. , Nov. 7, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today is providing an update of the regulatory and clinical path activities required to file a Biologics License Application (BLA) for Ampion for the treatment of severe osteoarthriti… read more...

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ampio Pharmaceuticals, Inc. to Contact The Firm

via: Business Wire at 2018-10-21 14:00:00:000

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ampio Pharmaceuticals, Inc. (Ampio or the Company) (NYSE:AMPE) of the October 24, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that … read more...

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ampio Pharmaceuticals, Inc. to Contact The Firm

via: Business Wire at 2018-10-21 14:00:00:000

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ampio Pharmaceuticals, Inc. (Ampio or the Company) (NYSE:AMPE) of the October 24, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that … read more...

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ampio Pharmaceuticals, Inc. to Contact The Firm

via: Business Wire at 2018-10-21 14:00:00:000

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ampio Pharmaceuticals, Inc. (Ampio or the Company) (NYSE:AMPE) of the October 24, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that … read more...

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 in Ampio Pharmaceuticals, Inc. to Contact the Firm

via: Business Wire at 2018-10-09 14:54:00:000

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ampio Pharmaceuticals, Inc. (Ampio or the Company) (NYSE:AMPE) of the October 24, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that … read more...

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 in Ampio Pharmaceuticals, Inc. to Contact the Firm

via: Business Wire at 2018-10-09 14:54:00:000

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ampio Pharmaceuticals, Inc. (Ampio or the Company) (NYSE:AMPE) of the October 24, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that … read more...

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 in Ampio Pharmaceuticals, Inc. to Contact the Firm

via: Business Wire at 2018-10-09 14:54:00:000

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ampio Pharmaceuticals, Inc. (Ampio or the Company) (NYSE:AMPE) of the October 24, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that … read more...

Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Ampio Pharmaceuticals, Inc.

via: Business Wire at 2018-10-08 18:38:00:000

National class action law firm Glancy Prongay & Murray LLP (GPM)reminds investors of the October 24, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Ampio Pharmaceuticals, Inc. (Ampi… read more...

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ampio Pharmaceuticals, Inc. To Contact The Firm

via: Business Wire at 2018-10-04 18:18:00:000

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ampio Pharmaceuticals, Inc. (Ampio or the Company) (NYSE:AMPE) of the October 24, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that … read more...

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ampio Pharmaceuticals, Inc. To Contact The Firm

via: Business Wire at 2018-10-04 18:18:00:000

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ampio Pharmaceuticals, Inc. (Ampio or the Company) (NYSE:AMPE) of the October 24, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that … read more...

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ampio Pharmaceuticals, Inc. To Contact The Firm

via: Business Wire at 2018-10-04 18:18:00:000

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ampio Pharmaceuticals, Inc. (Ampio or the Company) (NYSE:AMPE) of the October 24, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that … read more...

Ampio Provides Corporate Update

via: PR Newswire at 2018-10-04 08:30:00:000

ENGLEWOOD, Colo. , Oct. 4, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today provided an update of the ongoing Company activities required to file a Biologics License Application (BLA) for Ampion for the treatment of severe Osteoarthritis of the knee (OA… read more...

Ampio Provides Corporate Update

via: PR Newswire at 2018-10-04 08:30:00:000

ENGLEWOOD, Colo. , Oct. 4, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today provided an update of the ongoing Company activities required to file a Biologics License Application (BLA) for Ampion for the treatment of severe Osteoarthritis of the knee (OA… read more...

Ampio Provides Corporate Update

via: PR Newswire at 2018-10-04 08:30:00:000

ENGLEWOOD, Colo. , Oct. 4, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today provided an update of the ongoing Company activities required to file a Biologics License Application (BLA) for Ampion for the treatment of severe Osteoarthritis of the knee (OA… read more...

AMPE ALERT: Rosen Law Firm Files First Securities Class Action Lawsuit Against Ampio Pharmaceuticals, Inc.; Important Deadline - AMPE

via: PR Newswire at 2018-09-22 10:00:00:000

NEW YORK , Sept. 22, 2018 /PRNewswire/ --Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Ampio Pharmaceuticals, Inc. (NYSE: AMPE) from December 14, 2017 through August 7, 2018 , inclusiv… read more...

AMPE ALERT: Rosen Law Firm Files First Securities Class Action Lawsuit Against Ampio Pharmaceuticals, Inc.; Important Deadline - AMPE

via: PR Newswire at 2018-09-22 10:00:00:000

NEW YORK , Sept. 22, 2018 /PRNewswire/ --Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Ampio Pharmaceuticals, Inc. (NYSE: AMPE) from December 14, 2017 through August 7, 2018 , inclusiv… read more...

AMPE ALERT: Rosen Law Firm Files First Securities Class Action Lawsuit Against Ampio Pharmaceuticals, Inc.; Important Deadline - AMPE

via: PR Newswire at 2018-09-22 10:00:00:000

NEW YORK , Sept. 22, 2018 /PRNewswire/ --Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Ampio Pharmaceuticals, Inc. (NYSE: AMPE) from December 14, 2017 through August 7, 2018 , inclusiv… read more...

AMPE ALERT: Rosen Law Firm Files First Securities Class Action Lawsuit Against Ampio Pharmaceuticals, Inc.; Important Deadline - AMPE

via: PR Newswire at 2018-09-22 10:00:00:000

NEW YORK , Sept. 22, 2018 /PRNewswire/ --Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Ampio Pharmaceuticals, Inc. (NYSE: AMPE) from December 14, 2017 through August 7, 2018 , inclusiv… read more...

The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. (AMPE)

via: Business Wire at 2018-09-20 18:50:00:000

Law Offices of Howard G. Smithreminds investors of the October 24, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Ampio Pharmaceuticals, Inc. (Ampio or the Company) (NYSE: AMPE ) secu… read more...

The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. (AMPE)

via: Business Wire at 2018-09-20 18:50:00:000

Law Offices of Howard G. Smithreminds investors of the October 24, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Ampio Pharmaceuticals, Inc. (Ampio or the Company) (NYSE: AMPE ) secu… read more...

IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

via: Business Wire at 2018-09-19 12:57:00:000

The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (NYSE: AMPE ) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rul… read more...

IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

via: Business Wire at 2018-09-19 12:57:00:000

The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (NYSE: AMPE ) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rul… read more...

IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

via: Business Wire at 2018-09-19 12:57:00:000

The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (NYSE: AMPE ) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rul… read more...

Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Ampio Pharmaceuticals, Inc. Investors (AMPE)

via: Business Wire at 2018-09-18 19:13:00:000

Glancy Prongay & Murray LLP (GPM)announces that a class action lawsuit has been filed on behalf of investors that purchased or otherwise acquired securities of Ampio Pharmaceuticals, Inc.(Ampio or the Company) (NYSE: AMP… read more...

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

via: Business Wire at 2018-09-18 16:33:00:000

The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (NYSE: AMPE ) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rul… read more...

Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Ampio Pharmaceuticals, Inc. Investors

via: Business Wire at 2018-09-17 16:35:00:000

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors that purchased Ampio Pharmaceuticals, Inc. (Ampio or the Company) (NYSE: AMPE ) securities between December 14, 2017andAugust 7, 2018 … read more...

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ampio Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - AMPE

via: PR Newswire at 2018-09-17 10:00:00:000

NEW YORK , Sept. 17, 2018 /PRNewswire/ --Pomerantz LLP announces that a class action lawsuit has been filed against Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (NYSE: AMPE) and certain of its officers. The class action, filed in United States District … read more...

Ampio Reports Manuscript on the Mechanisms of Action (MOA) for Ampion(TM) accepted for Publication in "Clinical and Experimental Rheumatology(TM)"

via: PR Newswire at 2018-09-13 08:30:00:000

ENGLEWOOD, Colo. , Sept. 13, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced a basic science manuscript entitled " Clinically relevant re-differentiation of fibroblast-like chondrocytes into functional chondrocytes by the low molecular weight fractio… read more...

Ampio Reports Manuscript on the Mechanisms of Action (MOA) for Ampion(TM) accepted for Publication in "Clinical and Experimental Rheumatology(TM)"

via: PR Newswire at 2018-09-13 08:30:00:000

ENGLEWOOD, Colo. , Sept. 13, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced a basic science manuscript entitled " Clinically relevant re-differentiation of fibroblast-like chondrocytes into functional chondrocytes by the low molecular weight fractio… read more...

Ampio Reports Manuscript on the Mechanisms of Action (MOA) for Ampion(TM) accepted for Publication in "Clinical and Experimental Rheumatology(TM)"

via: PR Newswire at 2018-09-13 08:30:00:000

ENGLEWOOD, Colo. , Sept. 13, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced a basic science manuscript entitled " Clinically relevant re-differentiation of fibroblast-like chondrocytes into functional chondrocytes by the low molecular weight fractio… read more...

Robbins Arroyo LLP: Ampio Pharmaceuticals, Inc. (AMPE) Officers and Directors Breached Their Fiduciary Duties to Shareholders

via: Business Wire at 2018-09-12 17:56:00:000

Shareholder rights law firm Robbins Arroyo LLP announces that purchasers of Ampio Pharmaceuticals, Inc. (NYSE:AMPE) have filed a shareholder derivative complaint against the company's officers and directors for breaches of fiduciary duties beginning December 14, 2017 and continuing through… read more...

Lifshitz & Miller LLP Announces Investigation of Ampio Pharmaceuticals, CV Sciences, Inc., Facebook, Inc., Farmland Partners Inc., LogMeIn, Inc., Nevro Corporation, Sinclair Broadcast Group, Inc. and Tribune Media Company

via: PR Newswire at 2018-09-12 17:47:00:000

NEW YORK , Sept. 12, 2018 /PRNewswire/ -- Ampio Pharmaceuticals (AMPE) Lifshitz & Miller announces investigation into possible securities laws violations in connection with the effectiveness and adequacy of Ampio's AP-003-A and AP-003-C trials. If you are an Ampio inves… read more...

Dr. David Bar-Or retires as Chief Scientific Officer of Ampio Pharmaceuticals

via: PR Newswire at 2018-09-04 17:16:00:000

ENGLEWOOD, Colo. , Sept. 4, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that Dr. Bar-Or has decided to retire, effective September 30, 2018 , from his full-time position of Chief Science Officer (CSO) of Ampio but is retaining his positions on t… read more...

Dr. David Bar-Or retires as Chief Scientific Officer of Ampio Pharmaceuticals

via: PR Newswire at 2018-09-04 17:16:00:000

ENGLEWOOD, Colo. , Sept. 4, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that Dr. Bar-Or has decided to retire, effective September 30, 2018 , from his full-time position of Chief Science Officer (CSO) of Ampio but is retaining his positions on t… read more...

Dr. David Bar-Or retires as Chief Scientific Officer of Ampio Pharmaceuticals

via: PR Newswire at 2018-09-04 17:16:00:000

ENGLEWOOD, Colo. , Sept. 4, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that Dr. Bar-Or has decided to retire, effective September 30, 2018 , from his full-time position of Chief Science Officer (CSO) of Ampio but is retaining his positions on t… read more...

AMPE LOSS NOTICE: Rosen Law Firm Reminds Ampio Pharmaceuticals, Inc. Investors of Important Deadline in First Filed Case Commenced by Firm - AMPE

via: Business Wire at 2018-08-31 12:36:00:000

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ampio Pharmaceuticals, Inc. (NYSE:AMPE) from December 14, 2017 through August 7, 2018, inclusive (the Class Period) of the important October 24, 2018 lead plaintiff deadline in the clas… read more...

AMPE LOSS NOTICE: Rosen Law Firm Reminds Ampio Pharmaceuticals, Inc. Investors of Important Deadline in First Filed Case Commenced by Firm - AMPE

via: Business Wire at 2018-08-31 12:36:00:000

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ampio Pharmaceuticals, Inc. (NYSE:AMPE) from December 14, 2017 through August 7, 2018, inclusive (the Class Period) of the important October 24, 2018 lead plaintiff deadline in the clas… read more...

AMPE LOSS NOTICE: Rosen Law Firm Reminds Ampio Pharmaceuticals, Inc. Investors of Important Deadline in First Filed Case Commenced by Firm - AMPE

via: Business Wire at 2018-08-31 12:36:00:000

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ampio Pharmaceuticals, Inc. (NYSE:AMPE) from December 14, 2017 through August 7, 2018, inclusive (the Class Period) of the important October 24, 2018 lead plaintiff deadline in the clas… read more...

AMPE LOSS NOTICE: Rosen Law Firm Reminds Ampio Pharmaceuticals, Inc. Investors of Important Deadline in First Filed Case Commenced by Firm - AMPE

via: Business Wire at 2018-08-31 12:36:00:000

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ampio Pharmaceuticals, Inc. (NYSE:AMPE) from December 14, 2017 through August 7, 2018, inclusive (the Class Period) of the important October 24, 2018 lead plaintiff deadline in the clas… read more...

Robbins Arroyo LLP: Ampio Pharmaceuticals, Inc. (AMPE) Misled Shareholders According to a Recently Filed Class Action

via: Business Wire at 2018-08-30 19:31:00:000

Shareholder rights law firm Robbins Arroyo LLP announces that purchasers of Ampio Pharmaceuticals, Inc. (NYSE: AMPE) have filed a class action complaint against the company's officers and directors for alleged violations of the Securities Exchange Act of 1934 between December 14, 2017 and Au… read more...

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ampio Pharmaceuticals, Inc. To Contact The Firm

via: PR Newswire at 2018-08-27 18:16:00:000

NEW YORK , Aug. 27, 2018 /PRNewswire/ --Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (NYSE-MKT:AMPE) of the October 24, 2018 deadline to seek the role of lead plaintiff in a federal se… read more...

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ampio Pharmaceuticals, Inc. To Contact The Firm

via: PR Newswire at 2018-08-27 18:16:00:000

NEW YORK , Aug. 27, 2018 /PRNewswire/ --Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (NYSE-MKT:AMPE) of the October 24, 2018 deadline to seek the role of lead plaintiff in a federal se… read more...

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ampio Pharmaceuticals, Inc. To Contact The Firm

via: PR Newswire at 2018-08-27 18:16:00:000

NEW YORK , Aug. 27, 2018 /PRNewswire/ --Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (NYSE-MKT:AMPE) of the October 24, 2018 deadline to seek the role of lead plaintiff in a federal se… read more...

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Ampio Pharmaceuticals, Inc. (AMPE) and Lead Plaintiff Deadline - October 24, 2018

via: PR Newswire at 2018-08-27 10:10:00:000

NEW YORK , Aug. 27, 2018 /PRNewswire/ --Attorney Advertising --Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ampio Pharmaceuticals,Inc. ("Ampio" or the "Company") (NYSE: AMPE) and certain of its officers, on behalf… read more...

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Ampio Pharmaceuticals, Inc. (AMPE) and Lead Plaintiff Deadline - October 24, 2018

via: PR Newswire at 2018-08-27 10:10:00:000

NEW YORK , Aug. 27, 2018 /PRNewswire/ --Attorney Advertising --Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ampio Pharmaceuticals,Inc. ("Ampio" or the "Company") (NYSE: AMPE) and certain of its officers, on behalf… read more...

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Ampio Pharmaceuticals, Inc. (AMPE) and Lead Plaintiff Deadline - October 24, 2018

via: PR Newswire at 2018-08-27 10:10:00:000

NEW YORK , Aug. 27, 2018 /PRNewswire/ --Attorney Advertising --Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ampio Pharmaceuticals,Inc. ("Ampio" or the "Company") (NYSE: AMPE) and certain of its officers, on behalf… read more...

Ampio Class Action: Bernstein Liebhard LLP Announces That A Securities Class Action Lawsuit Has Been Filed Against Ampio Pharmaceuticals, Inc. - AMPE

via: PR Newswire at 2018-08-26 15:35:00:000

NEW YORK , Aug. 26, 2018 /PRNewswire/ -- Bernstein Liebhard LLP, anationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of those who purchased or acquired the securities of Ampio Pharmaceuticals,Inc. ("Ampio" o… read more...

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. - AMPE

via: Business Wire at 2018-08-25 11:03:00:000

Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Ampio Pharmaceuticals, Inc. (NYSE: AMPE) from December 14, 2017 through August 7, 2018, inclusive (the Class Period). The lawsuit seek… read more...

AMPIO INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Ampio Pharmaceuticals, Inc. To Contact The Firm

via: Business Wire at 2018-08-17 16:56:00:000

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ampio Pharmaceuticals, Inc. (Ampio or the Company) (NYSE:AMPE). If you invested in Ampio stock or options and would like to discuss your legal rig… read more...

AMPIO INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Ampio Pharmaceuticals, Inc. To Contact The Firm

via: Business Wire at 2018-08-17 16:56:00:000

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ampio Pharmaceuticals, Inc. (Ampio or the Company) (NYSE:AMPE). If you invested in Ampio stock or options and would like to discuss your legal rig… read more...

AMPIO INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Ampio Pharmaceuticals, Inc. To Contact The Firm

via: Business Wire at 2018-08-17 16:56:00:000

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ampio Pharmaceuticals, Inc. (Ampio or the Company) (NYSE:AMPE). If you invested in Ampio stock or options and would like to discuss your legal rig… read more...

AMPIO INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Ampio Pharmaceuticals, Inc. To Contact The Firm

via: Business Wire at 2018-08-17 16:56:00:000

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ampio Pharmaceuticals, Inc. (Ampio or the Company) (NYSE:AMPE). If you invested in Ampio stock or options and would like to discuss your legal rig… read more...

AMPIO INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Ampio Pharmaceuticals, Inc. To Contact The Firm

via: Business Wire at 2018-08-17 16:56:00:000

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ampio Pharmaceuticals, Inc. (Ampio or the Company) (NYSE:AMPE). If you invested in Ampio stock or options and would like to discuss your legal rig… read more...

Biotech Analysis Central Pharma News: Gemphire Pulls Plug, Ampio's FDA Despair, Paratek's Positive FDA Panel

via: SeekingAlpha at 2018-08-13 20:16:50:000

Welcome to Biotech Analysis Central Daily News, a daily news report and analysis about what has happened lately in the biotech industry. Gemphire Stops Study For treating Pediatric Patients With NASH News: This past Friday, shares of Gemphire Therapeutics ( GEMP ) fell by as much as 75… read more...

Biotech Analysis Central Pharma News: Gemphire Pulls Plug, Ampio's FDA Despair, Paratek's Positive FDA Panel

via: SeekingAlpha at 2018-08-13 20:16:50:000

Welcome to Biotech Analysis Central Daily News, a daily news report and analysis about what has happened lately in the biotech industry. Gemphire Stops Study For treating Pediatric Patients With NASH News: This past Friday, shares of Gemphire Therapeutics ( GEMP ) fell by as much as 75… read more...

Biotech Analysis Central Pharma News: Gemphire Pulls Plug, Ampio's FDA Despair, Paratek's Positive FDA Panel

via: SeekingAlpha at 2018-08-13 20:16:50:000

Welcome to Biotech Analysis Central Daily News, a daily news report and analysis about what has happened lately in the biotech industry. Gemphire Stops Study For treating Pediatric Patients With NASH News: This past Friday, shares of Gemphire Therapeutics ( GEMP ) fell by as much as 75… read more...

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Ampio Pharmaceuticals, Inc. (AMPE)

via: PR Newswire at 2018-08-10 14:56:00:000

NEW YORK , Aug. 10, 2018 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (NYSE American:AMPE). Such investors are encouraged to obtain a… read more...

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Ampio Pharmaceuticals, Inc. (AMPE)

via: PR Newswire at 2018-08-10 14:56:00:000

NEW YORK , Aug. 10, 2018 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (NYSE American:AMPE). Such investors are encouraged to obtain a… read more...

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Ampio Pharmaceuticals, Inc. (AMPE)

via: PR Newswire at 2018-08-10 14:56:00:000

NEW YORK , Aug. 10, 2018 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (NYSE American:AMPE). Such investors are encouraged to obtain a… read more...

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Ampio Pharmaceuticals, Inc. (AMPE)

via: PR Newswire at 2018-08-10 14:56:00:000

NEW YORK , Aug. 10, 2018 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (NYSE American:AMPE). Such investors are encouraged to obtain a… read more...

INVESTIGATION REMINDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ampio Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

via: Business Wire at 2018-08-10 09:38:00:000

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ampio Pharmaceuticals, Inc. (Ampio or the Company) (NYSE: AMPE ) for violations of 10(b) and 20(a) of the Sec… read more...

INVESTIGATION REMINDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ampio Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

via: Business Wire at 2018-08-10 09:38:00:000

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ampio Pharmaceuticals, Inc. (Ampio or the Company) (NYSE: AMPE ) for violations of 10(b) and 20(a) of the Sec… read more...

INVESTIGATION REMINDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ampio Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

via: Business Wire at 2018-08-10 09:38:00:000

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ampio Pharmaceuticals, Inc. (Ampio or the Company) (NYSE: AMPE ) for violations of 10(b) and 20(a) of the Sec… read more...

INVESTIGATION REMINDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ampio Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

via: Business Wire at 2018-08-10 09:38:00:000

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ampio Pharmaceuticals, Inc. (Ampio or the Company) (NYSE: AMPE ) for violations of 10(b) and 20(a) of the Sec… read more...

AMPIO INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Ampio Pharmaceuticals, Inc. To Contact The Firm

via: PR Newswire at 2018-08-09 17:35:00:000

NEW YORK , Aug. 9, 2018 /PRNewswire/ --Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (NYSE-MKT:AMPE). If you invested in Ampio stock or options and would l… read more...

Ampio Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock and Warrants

via: PR Newswire at 2018-08-09 08:40:00:000

ENGLEWOOD, Colo. , Aug. 9, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) ("Ampio"), a clinical trial stage biopharmaceutical company primarily focused on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment … read more...

Ampio Pharmaceuticals announces common stock offering and Warrants

via: SeekingAlpha at 2018-08-09 05:02:40:000

Ampio Pharmaceuticals (NYSEMKT: AMPE ) intends to offer and sell common shares and accompanying warrants to purchase shares of common stock in an underwritten public offering. More news on: Ampio Pharmaceuticals, Inc., Healthcare stocks news, Read more … read more...

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ampio Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

via: Business Wire at 2018-08-08 23:00:00:000

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ampio Pharmaceuticals, Inc. (Ampio or the Company) (NYSE: AMPE ) for violations of 10(b) and 20(a) of the Sec… read more...

Ampio Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Warrants

via: PR Newswire at 2018-08-08 17:15:00:000

ENGLEWOOD, Colo. , Aug. 8, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) ("Ampio"), a clinical trial stage biopharmaceutical company primarily focused on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment … read more...

Investor Alert: Kaplan Fox Announces Investigation Of Ampio Pharmaceuticals, Inc.

via: PR Newswire at 2018-08-08 16:41:00:000

NEW YORK , Aug. 8, 2018 /PRNewswire/ --Kaplan Fox & Kilsheimer LLP ( www.kaplanfox.com ) is investigating Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") (NYSE: AMPE) concerning potential securities law violations. Investors who purchased Ampio securities may be aff… read more...

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Ampio Pharmaceuticals, Inc. - AMPE

via: Business Wire at 2018-08-08 14:46:00:000

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Ampio Pharmaceuticals, Inc. (NYSE: AMPE) resulting from allegations that Ampio may have issued materially misleading business information to the investing… read more...

Midday Gainers / Losers (08/08/2018)

via: SeekingAlpha at 2018-08-08 12:40:10:000

Gainers: ABIL +185% . DDD +31% . ATAI +30% . ENDP +30% . VSI +28% . MTSL +23% . CARG +23% . ETM +22% . CSTE +19% . VEC +18% . Losers: AMPE -69% . EXTR -30% . CMT -26% . TMDI -22% . FTK -22% . XOMA -21% . CHKE -18% . CBB -18% . CH… read more...

AMPE Alert: Bernstein Liebhard LLP Announces Investigation Of Ampio Pharmaceuticals, Inc. - AMPE

via: PR Newswire at 2018-08-08 12:10:00:000

NEW YORK , Aug. 8, 2018 /PRNewswire/ --Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, is investigating potential securities fraud claims on behalf of shareholders of Ampio Pharmaceuticals, Inc.("Ampio" or the "Company") (NYSE MKT: AMPE) resulting from… read more...

Premarket Losers as of 9:05 am (8/8/2018)

via: SeekingAlpha at 2018-08-08 09:18:20:000

AMPE -70% . More news on: Ampio Pharmaceuticals, Inc., Titan Medical Inc., Extreme Networks, Inc., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (08/06/2018)

via: SeekingAlpha at 2018-08-06 12:46:39:000

Gainers: PTGX +36% . BLNK +33% . TCCO +30% . UONE +20% . HMNY +16% . SEAS +18% . TTOO +15% . OPRA +15% . ICPT +15% . AMPE +14% . More news on: Protagonist Therapeutics, Blink Charging Co., Technical Communications Corp., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (08/06/2018)

via: SeekingAlpha at 2018-08-06 12:46:39:000

Gainers: PTGX +36% . BLNK +33% . TCCO +30% . UONE +20% . HMNY +16% . SEAS +18% . TTOO +15% . OPRA +15% . ICPT +15% . AMPE +14% . More news on: Protagonist Therapeutics, Blink Charging Co., Technical Communications Corp., Stocks on the move, , Read more … read more...

Ampio Hosting Conference Call Tuesday, August 7, 4:30 pm EDT to Update the Preparation of the Biologics License Application (BLA) for Ampion(TM)

via: PR Newswire at 2018-08-06 08:30:00:000

ENGLEWOOD, Colo. , Aug. 6, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT:AMPE) hosting a conference call Tuesday, August 7th at 4:30 pm EDT to update the preparation of the Biologics License Application (BLA) for Ampion. Participants are invited to dial… read more...

Ampio Hosting Conference Call Tuesday, August 7, 4:30 pm EDT to Update the Preparation of the Biologics License Application (BLA) for Ampion(TM)

via: PR Newswire at 2018-08-06 08:30:00:000

ENGLEWOOD, Colo. , Aug. 6, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT:AMPE) hosting a conference call Tuesday, August 7th at 4:30 pm EDT to update the preparation of the Biologics License Application (BLA) for Ampion. Participants are invited to dial… read more...

Ampio Pharmaceuticals, Inc. to Present at the 38th Annual Canaccord Genuity Growth Conference

via: PR Newswire at 2018-08-02 08:30:00:000

ENGLEWOOD, Colo. , August 2, 2018 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE: AMPE) a clinical trial stage biopharmaceutical company primarily focused on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options, today ann… read more...

Ampio Pharmaceuticals, Inc. to Present at the 38th Annual Canaccord Genuity Growth Conference

via: PR Newswire at 2018-08-02 08:30:00:000

ENGLEWOOD, Colo. , August 2, 2018 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE: AMPE) a clinical trial stage biopharmaceutical company primarily focused on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options, today ann… read more...

Ampio Pharmaceuticals, Inc. to Present at the 38th Annual Canaccord Genuity Growth Conference

via: PR Newswire at 2018-08-02 08:30:00:000

ENGLEWOOD, Colo. , August 2, 2018 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE: AMPE) a clinical trial stage biopharmaceutical company primarily focused on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options, today ann… read more...

Premarket Gainers as of 9:05 am (07/27/2018)

via: SeekingAlpha at 2018-07-27 09:20:50:000

IZEA +16% on closing of Tapinfluence acquisition. More news on: IZEA Inc., Atlassian, Tetraphase Pharmaceuticals, Stocks on the move, , Read more … read more...

Premarket Gainers as of 9:05 am (07/27/2018)

via: SeekingAlpha at 2018-07-27 09:20:50:000

IZEA +16% on closing of Tapinfluence acquisition. More news on: IZEA Inc., Atlassian, Tetraphase Pharmaceuticals, Stocks on the move, , Read more … read more...

Premarket Gainers as of 9:05 am (07/27/2018)

via: SeekingAlpha at 2018-07-27 09:20:50:000

IZEA +16% on closing of Tapinfluence acquisition. More news on: IZEA Inc., Atlassian, Tetraphase Pharmaceuticals, Stocks on the move, , Read more … read more...

Premarket Gainers as of 9:05 am (07/27/2018)

via: SeekingAlpha at 2018-07-27 09:20:50:000

IZEA +16% on closing of Tapinfluence acquisition. More news on: IZEA Inc., Atlassian, Tetraphase Pharmaceuticals, Stocks on the move, , Read more … read more...

Premarket Gainers as of 9:05 am (07/27/2018)

via: SeekingAlpha at 2018-07-27 09:20:50:000

IZEA +16% on closing of Tapinfluence acquisition. More news on: IZEA Inc., Atlassian, Tetraphase Pharmaceuticals, Stocks on the move, , Read more … read more...

Midday Gainers / Losers (07/20/2018)

via: SeekingAlpha at 2018-07-20 12:43:24:000

Gainers: SAEX +26% . NBEV +16% . CLF +15% . SEED +14% . AMPE +14% . SSLJ +13% . LBIX +13% . AXE +13% . CSLT +12% . MRTX +12% . More news on: SAExploration Holdings, Inc., New Age Beverages Corporation, Cleveland-Cliffs, Inc., Stocks on the move, , … read more...

Midday Gainers / Losers (07/20/2018)

via: SeekingAlpha at 2018-07-20 12:43:24:000

Gainers: SAEX +26% . NBEV +16% . CLF +15% . SEED +14% . AMPE +14% . SSLJ +13% . LBIX +13% . AXE +13% . CSLT +12% . MRTX +12% . More news on: SAExploration Holdings, Inc., New Age Beverages Corporation, Cleveland-Cliffs, Inc., Stocks on the move, , … read more...

Midday Gainers / Losers (07/20/2018)

via: SeekingAlpha at 2018-07-20 12:43:24:000

Gainers: SAEX +26% . NBEV +16% . CLF +15% . SEED +14% . AMPE +14% . SSLJ +13% . LBIX +13% . AXE +13% . CSLT +12% . MRTX +12% . More news on: SAExploration Holdings, Inc., New Age Beverages Corporation, Cleveland-Cliffs, Inc., Stocks on the move, , … read more...

Midday Gainers / Losers (07/20/2018)

via: SeekingAlpha at 2018-07-20 12:43:24:000

Gainers: SAEX +26% . NBEV +16% . CLF +15% . SEED +14% . AMPE +14% . SSLJ +13% . LBIX +13% . AXE +13% . CSLT +12% . MRTX +12% . More news on: SAExploration Holdings, Inc., New Age Beverages Corporation, Cleveland-Cliffs, Inc., Stocks on the move, , … read more...

Midday Gainers / Losers (07/20/2018)

via: SeekingAlpha at 2018-07-20 12:43:24:000

Gainers: SAEX +26% . NBEV +16% . CLF +15% . SEED +14% . AMPE +14% . SSLJ +13% . LBIX +13% . AXE +13% . CSLT +12% . MRTX +12% . More news on: SAExploration Holdings, Inc., New Age Beverages Corporation, Cleveland-Cliffs, Inc., Stocks on the move, , … read more...

Ampio provides a Link to New Publication on the Mechanism of Action for Ampion(TM)

via: PR Newswire at 2018-07-12 12:45:00:000

ENGLEWOOD, Colo. , July 12, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced a basic science manuscript entitled "The Anti-Inflammatory Effect of LMWF5A and N-Acetyl Kynurenine on Macrophages: Involvement of Aryl Hydrocarbon Receptor in Mechanism of … read more...

Ampio provides a Link to New Publication on the Mechanism of Action for Ampion(TM)

via: PR Newswire at 2018-07-12 12:45:00:000

ENGLEWOOD, Colo. , July 12, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced a basic science manuscript entitled "The Anti-Inflammatory Effect of LMWF5A and N-Acetyl Kynurenine on Macrophages: Involvement of Aryl Hydrocarbon Receptor in Mechanism of … read more...

Ampio provides a Link to New Publication on the Mechanism of Action for Ampion(TM)

via: PR Newswire at 2018-07-12 12:45:00:000

ENGLEWOOD, Colo. , July 12, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced a basic science manuscript entitled "The Anti-Inflammatory Effect of LMWF5A and N-Acetyl Kynurenine on Macrophages: Involvement of Aryl Hydrocarbon Receptor in Mechanism of … read more...

Ampio Reports New Publication on the Mechanisms of Action for Ampion(TM)

via: PR Newswire at 2018-06-27 08:30:00:000

ENGLEWOOD, Colo. , June 27, 2018 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced a basic science manuscript entitled "The Anti-Inflammatory Effect of LMWF5A and N-Acetyl Kynurenine on Macrophages: Involvement of Aryl Hydrocarbon Receptor in Mechanism o… read more...

Ampio Reports New Publication on the Mechanisms of Action for Ampion(TM)

via: PR Newswire at 2018-06-27 08:30:00:000

ENGLEWOOD, Colo. , June 27, 2018 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced a basic science manuscript entitled "The Anti-Inflammatory Effect of LMWF5A and N-Acetyl Kynurenine on Macrophages: Involvement of Aryl Hydrocarbon Receptor in Mechanism o… read more...

Ampio Reports New Publication on the Mechanisms of Action for Ampion(TM)

via: PR Newswire at 2018-06-27 08:30:00:000

ENGLEWOOD, Colo. , June 27, 2018 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced a basic science manuscript entitled "The Anti-Inflammatory Effect of LMWF5A and N-Acetyl Kynurenine on Macrophages: Involvement of Aryl Hydrocarbon Receptor in Mechanism o… read more...

Ampio Provides Scientific Update and Links to Peer Review Publications

via: PR Newswire at 2018-06-05 08:30:00:000

ENGLEWOOD, Colo. , June 5, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced two peer-reviewed articles on the clinical application of Ampionare now available online. "Peer-reviewed journals are an important part of the scientif… read more...

Ampio Provides Scientific Update and Links to Peer Review Publications

via: PR Newswire at 2018-06-05 08:30:00:000

ENGLEWOOD, Colo. , June 5, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced two peer-reviewed articles on the clinical application of Ampionare now available online. "Peer-reviewed journals are an important part of the scientif… read more...

Ampio Provides Scientific Update and Links to Peer Review Publications

via: PR Newswire at 2018-06-05 08:30:00:000

ENGLEWOOD, Colo. , June 5, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced two peer-reviewed articles on the clinical application of Ampionare now available online. "Peer-reviewed journals are an important part of the scientif… read more...

Your Daily Pharma Scoop: 4 NDAs... CPRX, EXEL, ALPMY, ACOR

via: SeekingAlpha at 2018-05-31 04:17:16:000

Analysis Focus: CPRX Catalyst Pharmaceuticals (CPRX) is a smallcap company with $363M in market capitalization. The company was founded as Catalyst Pharmaceutical Partners, Inc. in 2002 and is based in Coral Gables, Florida. Their focus is on development and commercialization of therapies … read more...

Your Daily Pharma Scoop: 4 NDAs... CPRX, EXEL, ALPMY, ACOR

via: SeekingAlpha at 2018-05-31 04:17:16:000

Analysis Focus: CPRX Catalyst Pharmaceuticals (CPRX) is a smallcap company with $363M in market capitalization. The company was founded as Catalyst Pharmaceutical Partners, Inc. in 2002 and is based in Coral Gables, Florida. Their focus is on development and commercialization of therapies … read more...

Your Daily Pharma Scoop: 4 NDAs... CPRX, EXEL, ALPMY, ACOR

via: SeekingAlpha at 2018-05-31 04:17:16:000

Analysis Focus: CPRX Catalyst Pharmaceuticals (CPRX) is a smallcap company with $363M in market capitalization. The company was founded as Catalyst Pharmaceutical Partners, Inc. in 2002 and is based in Coral Gables, Florida. Their focus is on development and commercialization of therapies … read more...

Midday Gainers / Losers (05/29/2018)

via: SeekingAlpha at 2018-05-29 12:35:38:000

Gainers: CODX +65% . AXON +30% . ATV +24% . DHX +22% . MYND +19% . TUSK +19% . OCX +17% . LEJU +16% . MOMO +15% . EMX +15% . More news on: Co-Diagnostics, Axovant Sciences, Acorn International, Inc., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (05/29/2018)

via: SeekingAlpha at 2018-05-29 12:35:38:000

Gainers: CODX +65% . AXON +30% . ATV +24% . DHX +22% . MYND +19% . TUSK +19% . OCX +17% . LEJU +16% . MOMO +15% . EMX +15% . More news on: Co-Diagnostics, Axovant Sciences, Acorn International, Inc., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (05/29/2018)

via: SeekingAlpha at 2018-05-29 12:35:38:000

Gainers: CODX +65% . AXON +30% . ATV +24% . DHX +22% . MYND +19% . TUSK +19% . OCX +17% . LEJU +16% . MOMO +15% . EMX +15% . More news on: Co-Diagnostics, Axovant Sciences, Acorn International, Inc., Stocks on the move, , Read more … read more...

Ampio to meet with FDA in July on Ampion BLA; shares down 15%

via: SeekingAlpha at 2018-05-29 11:57:15:000

Ampio Pharmaceuticals ( AMPE -15.1% ) slumps on 40% higher volume in apparent response to its planned meeting with the FDA to discuss its BLA submission for Ampion for the treatment of osteoarthritis of the knee. Investors appear disappointed with the timeline, as the meeting is set for Ju… read more...

Ampio to meet with FDA in July on Ampion BLA; shares down 15%

via: SeekingAlpha at 2018-05-29 11:57:15:000

Ampio Pharmaceuticals ( AMPE -15.1% ) slumps on 40% higher volume in apparent response to its planned meeting with the FDA to discuss its BLA submission for Ampion for the treatment of osteoarthritis of the knee. Investors appear disappointed with the timeline, as the meeting is set for Ju… read more...

Ampio to meet with FDA in July on Ampion BLA; shares down 15%

via: SeekingAlpha at 2018-05-29 11:57:15:000

Ampio Pharmaceuticals ( AMPE -15.1% ) slumps on 40% higher volume in apparent response to its planned meeting with the FDA to discuss its BLA submission for Ampion for the treatment of osteoarthritis of the knee. Investors appear disappointed with the timeline, as the meeting is set for Ju… read more...

Ampio Updates Regulatory and IP Activities

via: PR Newswire at 2018-05-29 08:30:00:000

ENGLEWOOD, Colo. , May 29, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced: The Company and the FDA have agreed to a July 2018 meeting to continue their discussions on the BLA submission being prepared for Ampion as a treatment of the … read more...

Ampio Updates Regulatory and IP Activities

via: PR Newswire at 2018-05-29 08:30:00:000

ENGLEWOOD, Colo. , May 29, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced: The Company and the FDA have agreed to a July 2018 meeting to continue their discussions on the BLA submission being prepared for Ampion as a treatment of the … read more...

Ampio Updates Regulatory and IP Activities

via: PR Newswire at 2018-05-29 08:30:00:000

ENGLEWOOD, Colo. , May 29, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced: The Company and the FDA have agreed to a July 2018 meeting to continue their discussions on the BLA submission being prepared for Ampion as a treatment of the … read more...

Ampio Updates Scientific presentations and publications on Ampion(TM)

via: PR Newswire at 2018-05-22 08:30:00:000

ENGLEWOOD, Colo. , May 22, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced a poster presentation on the mechanism of action of a component of Ampion will be presented at AAST and the most recent study of Ampion treatment of Severe Osteoarthri… read more...

Warrant You Glad You're Not Long Ampio?

via: SeekingAlpha at 2018-05-15 09:48:52:000

Editor's note: Seeking Alpha is proud to welcome Tau Equity Research as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more Edito… read more...

Warrant You Glad You're Not Long Ampio?

via: SeekingAlpha at 2018-05-15 09:48:52:000

Editor's note: Seeking Alpha is proud to welcome Tau Equity Research as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more Edito… read more...

Warrant You Glad You're Not Long Ampio?

via: SeekingAlpha at 2018-05-15 09:48:52:000

Editor's note: Seeking Alpha is proud to welcome Tau Equity Research as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more Edito… read more...

Warrant You Glad You're Not Long Ampio?

via: SeekingAlpha at 2018-05-15 09:48:52:000

Editor's note: Seeking Alpha is proud to welcome Tau Equity Research as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more Edito… read more...

Warrant You Glad You're Not Long Ampio?

via: SeekingAlpha at 2018-05-15 09:48:52:000

Editor's note: Seeking Alpha is proud to welcome Tau Equity Research as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more Edito… read more...

Warrant You Glad You're Not Long Ampio?

via: SeekingAlpha at 2018-05-15 09:48:52:000

Editor's note: Seeking Alpha is proud to welcome Tau Equity Research as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more Edito… read more...

Ampio Provides Corporate Update

via: PR Newswire at 2018-05-14 08:30:00:000

ENGLEWOOD, Colo. , May 14, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE), a developer of novel therapeutics to address significant inflammatory conditions for which limited treatment options exist, today announced updates to shareholders that address questions rec… read more...

Ampio Provides Corporate Update

via: PR Newswire at 2018-05-14 08:30:00:000

ENGLEWOOD, Colo. , May 14, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE), a developer of novel therapeutics to address significant inflammatory conditions for which limited treatment options exist, today announced updates to shareholders that address questions rec… read more...

The Pivotal Trial Results on Ampion(TM) (AP-003-C) Was Accepted for Publication in a Peer-Reviewed Medical Journal

via: PR Newswire at 2018-05-02 08:30:00:000

ENGLEWOOD, Colo. , May 2, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that the publication entitled: "Intra-articular injection of the anti-inflammatory compound LMWF-5A (Ampion) in adults with severe osteoarthritis: a double-blind prospe… read more...

The Pivotal Trial Results on Ampion(TM) (AP-003-C) Was Accepted for Publication in a Peer-Reviewed Medical Journal

via: PR Newswire at 2018-05-02 08:30:00:000

ENGLEWOOD, Colo. , May 2, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that the publication entitled: "Intra-articular injection of the anti-inflammatory compound LMWF-5A (Ampion) in adults with severe osteoarthritis: a double-blind prospe… read more...

Your Daily Pharma Scoop: Intercept's OCA, MediciNova In NASH, Pulse Biosciences Data

via: SeekingAlpha at 2018-04-16 08:00:00:000

A nalysis focus: Intercept Intercept Pharmaceuticals ( ICPT ) reported clinical data from a liver biopsy-based substudy from its phase 3 POISE study. The study indicated that long-term OCA treatment in patients with PBC led to reversal or stabilization of fibrosis and cirrhosis. … read more...

Your Daily Pharma Scoop: Intercept's OCA, MediciNova In NASH, Pulse Biosciences Data

via: SeekingAlpha at 2018-04-16 08:00:00:000

A nalysis focus: Intercept Intercept Pharmaceuticals ( ICPT ) reported clinical data from a liver biopsy-based substudy from its phase 3 POISE study. The study indicated that long-term OCA treatment in patients with PBC led to reversal or stabilization of fibrosis and cirrhosis. … read more...

The Battle For Ampio Pharmaceuticals Reaches Inflection Point As Shorts Run Out Of Gas

via: SeekingAlpha at 2018-04-13 12:40:16:000

Ampio Pharmaceuticals (NASDAQ: AMPE ) has made it clear to Wall Street that the company is up for sale. In a recent ad hoc twitter poll the most likely suitor to buy AMPE is Merck (NYSE: MRK ) with 36% of the vote followed by Johnson and Johnson (NYSE: JNJ ) with 32%, Pfizer(NYSE: PFE ) with… read more...

The Battle For Ampio Pharmaceuticals Reaches Inflection Point As Shorts Run Out Of Gas

via: SeekingAlpha at 2018-04-13 12:40:16:000

Ampio Pharmaceuticals (NASDAQ: AMPE ) has made it clear to Wall Street that the company is up for sale. In a recent ad hoc twitter poll the most likely suitor to buy AMPE is Merck (NYSE: MRK ) with 36% of the vote followed by Johnson and Johnson (NYSE: JNJ ) with 32%, Pfizer(NYSE: PFE ) with… read more...

Ampio updates regulatory, clinical and NYSE activities

via: SeekingAlpha at 2018-04-13 07:31:36:000

Ampio Pharmaceuticals (NASDAQ: AMPE ) has begun preliminary discussions with the FDA on details of the Biologics License Application (BLA) submission process for Ampion, a treatment for severe osteoarthritis-of-the-knee. More news on: Ampio Pharmaceuticals, Inc., Healthcare stocks news, … read more...

Ampio updates regulatory, clinical and NYSE activities

via: SeekingAlpha at 2018-04-13 07:31:36:000

Ampio Pharmaceuticals (NASDAQ: AMPE ) has begun preliminary discussions with the FDA on details of the Biologics License Application (BLA) submission process for Ampion, a treatment for severe osteoarthritis-of-the-knee. More news on: Ampio Pharmaceuticals, Inc., Healthcare stocks news, … read more...

Ampio Updates Regulatory, Clinical and NYSE Activities

via: PR Newswire at 2018-04-12 17:40:00:000

ENGLEWOOD, Colo. , April 12, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announces the Company has begun preliminary discussions with the Food and Drug Administration on details of the Biologics License Application (BLA) submission process for Ampion&#x212… read more...

Ampio Updates Regulatory, Clinical and NYSE Activities

via: PR Newswire at 2018-04-12 17:40:00:000

ENGLEWOOD, Colo. , April 12, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announces the Company has begun preliminary discussions with the Food and Drug Administration on details of the Biologics License Application (BLA) submission process for Ampion&#x212… read more...

Ampio Pharmaceuticals: Cash Critically Low, Pattern Of Exaggerated Claims Continues

via: SeekingAlpha at 2018-04-12 10:00:00:000

Ampio Pharmaceuticals ( AMPE ) stock is trading near its highest levels of the year with an enterprise value of approximately $330m despite poor prospects of its sole drug in development and a very low probability of an economically attractive partnership or buyout. The last reported net cash … read more...

Ampio Pharmaceuticals: Cash Critically Low, Pattern Of Exaggerated Claims Continues

via: SeekingAlpha at 2018-04-12 10:00:00:000

Ampio Pharmaceuticals ( AMPE ) stock is trading near its highest levels of the year with an enterprise value of approximately $330m despite poor prospects of its sole drug in development and a very low probability of an economically attractive partnership or buyout. The last reported net cash … read more...

Midday Gainers / Losers (04/10/2018)

via: SeekingAlpha at 2018-04-10 12:40:22:000

Gainers: PAY +52% . KONE +47% . CNET +35% . SPPI +31% . TNDM +20% . PIXY +16% . OSN +15% . SYNL +13% . NEWA +13% . JRJC +13% . More news on: VeriFone Systems, Inc., Kingtone Wirelessinfo Solution Holding Ltd, ChinaNet Online Holdings, Inc., Stocks on the mo… read more...

Midday Gainers / Losers (04/10/2018)

via: SeekingAlpha at 2018-04-10 12:40:22:000

Gainers: PAY +52% . KONE +47% . CNET +35% . SPPI +31% . TNDM +20% . PIXY +16% . OSN +15% . SYNL +13% . NEWA +13% . JRJC +13% . More news on: VeriFone Systems, Inc., Kingtone Wirelessinfo Solution Holding Ltd, ChinaNet Online Holdings, Inc., Stocks on the mo… read more...

Ampio Updates Regulatory and Clinical Activities

via: PR Newswire at 2018-04-03 08:30:00:000

ENGLEWOOD, Colo. , April 3, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announces the Company has retained PAREXEL ( www.parexel.com/ ) to assist in preparing and presenting the Biologics License Application (BLA) for Ampion for th… read more...

Ampio Update of J.P. Morgan Meeting Events and Disease Modification Discussions

via: PR Newswire at 2018-01-16 08:30:00:000

ENGLEWOOD, Colo. , Jan. 16, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today reported a heavy schedule of meetings throughout the four-day conference, predominately with significant pharmaceutical companies discussing the successful clinical results of the comp… read more...

Premarket Gainers as of 9:05 am

via: SeekingAlpha at 2018-01-08 09:21:31:000

SPCB +62% in process of developing various cryptocurrency capabilities for its SuperPay secure mobile money suite. More news on: SuperCom, Ltd., MySize Inc., LightInTheBox Holding Co., Ltd., Stocks on the move, Read more … read more...

Ampio Presentation at J.P. Morgan Healthcare Conference made available to all Shareholders

via: PR Newswire at 2018-01-08 08:30:00:000

ENGLEWOOD, Colo. , Jan. 8, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) announces that the company will be updating potential collaborators and attending shareholders at the J.P. Morgan Healthcare Conference, the largest and most informative healthcare in… read more...

Premarket Losers as of 9:05 am

via: SeekingAlpha at 2018-01-05 09:14:55:000

OHRP -79% on failure of MAKO study. More news on: Ohr Pharmaceutical, Inc., Francesca's Holdings Corp., REGENXBIO, Stocks on the move, Read more … read more...

Midday Gainers / Losers

via: SeekingAlpha at 2018-01-04 12:40:33:000

Gainers: CNET +315% . APOP +48% . HTGM +42% . AEMD +42% . CCXI +34% . OMF +24% . CMCM +20% . CCCR +18% . TCCO +17% . APHB +17% . More news on: ChinaNet Online Holdings, Inc., Cellect Biotechnology Ltd., HTG Molecular Diagnostics, Stocks on the move, Rea… read more...

Midday Gainers / Losers

via: SeekingAlpha at 2018-01-03 12:47:07:000

Gainers: HGSH +132% . CHCI +45% . ARWR +26% . LEDS +22% . SCG +22% . REXX +18% . RENN +18% . CHRS +18% . TEUM +16% . INSY +16% . More news on: China HGS Real Estate, Inc., Comstock Homebuilding Companies, Inc., Arrowhead Pharmaceuticals, Stocks on the move,… read more...

Ampio trading halted for volatility

via: SeekingAlpha at 2018-01-02 13:39:48:000

Nasdaq has suspended trading in Ampio Pharmaceuticals ( AMPE -24.1% ) due to volatility. Shares were down on almost double normal volume when halted. More news on: Ampio Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Midday Gainers / Losers

via: SeekingAlpha at 2018-01-02 12:45:29:000

Gainers: CHCI +60% . BURG +45% . MICT +25% . SYBX +24% . NETE +23% . RENN +18% . MNKD +17% . APLP +17% . WATT +16% . NTEC +15% . More news on: Comstock Homebuilding Companies, Inc., Chanticleer Holdings, Micronet Enertec Technologies, Inc., Stocks on the mo… read more...

Premarket Gainers as of 9:05 am

via: SeekingAlpha at 2017-12-19 09:18:37:000

CREG +57% signed a contract with Shanghai Electric Distributed Energy Sources Technology. More news on: China Recycling Energy Corporation, NXT-ID Inc., On Track Innovations Ltd, Stocks on the move, Read more … read more...

3 Things In Biotech You Should Learn Today: December 17, 2017

via: SeekingAlpha at 2017-12-17 08:05:28:000

Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research. Puma is getting to pounce in Europe Company: Puma Biotechnology ( PBYI ) Therapy: Ner… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided for free by IEX